Stopped
Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine · Nasopharyngeal Carcinoma
Trial status changed: Recruiting → Withdrawn
Also in this update: Primary completion moved earlier from Dec 1, 2026 to Mar 31, 2026; Study completion moved earlier from Jan 1, 2027 to Mar 31, 2026
Fifth Affiliated Hospital, Sun Yat-Sen UniversityPhase 2 NCT05290194 Registry history of NCT05290194 on ClinicalTrials.gov (opens the registry)